DBV Technologies (DBVT) News Today $7.79 +0.47 (+6.42%) As of 04/14/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period DBV Technologies S.A.: DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration DocumentApril 11, 2025 | finanznachrichten.deDBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration DocumentApril 11, 2025 | globenewswire.com3 Biopharmaceutical Stocks Bucking the Sell-Off (DBVT)Three biopharma companies may appeal to investors looking for firms that have not been rocked by tariff-inspired turbulence.April 10, 2025 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Coverage Initiated at StockNews.comStockNews.com assumed coverage on shares of DBV Technologies in a research note on Monday. They issued a "hold" rating on the stock.April 8, 2025 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Coverage Initiated by Analysts at StockNews.comStockNews.com started coverage on shares of DBV Technologies in a research report on Sunday. They set a "hold" rating for the company.March 30, 2025 | marketbeat.comDBV Technologies ADRs Rise After Up to $306.9M in New FinancingMarch 28, 2025 | marketwatch.comDBV Technologies announces up to $307M financing to advance Viaskin Peanut programMarch 28, 2025 | msn.comDBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if ApprovedMarch 27, 2025 | globenewswire.comDBV sinks after disclosing ‘substantial doubt’ of going concernMarch 26, 2025 | markets.businessinsider.comDBV reports VITESSE trial sufficient to support BLA, discontinues COMFORT trialMarch 25, 2025 | markets.businessinsider.comDBV's ADRs Fall After Going-Concern Warning as Cash Dries UpMarch 24, 2025 | marketwatch.comDBV Technologies faces cash shortage, stock dropsMarch 24, 2025 | investing.comDBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial ResultsMarch 24, 2025 | globenewswire.comYiheng Capital Management L.P. Sells 2,497,267 Shares of DBV Technologies S.A. (NASDAQ:DBVT)Yiheng Capital Management L.P. decreased its position in shares of DBV Technologies S.A. (NASDAQ:DBVT - Free Report) by 79.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 656,309 sharMarch 22, 2025 | marketbeat.comDBV Technologies (DBVT) to Release Earnings on ThursdayDBV Technologies (NASDAQ:DBVT) will be releasing earnings before the market opens on Thursday, March 6, Financial Modeling Prep reports.February 27, 2025 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Earns Hold Rating from Analysts at StockNews.comStockNews.com initiated coverage on shares of DBV Technologies in a report on Wednesday. They issued a "hold" rating on the stock.February 26, 2025 | marketbeat.comDBV Technologies to Participate in Upcoming AAAAI/WAO Joint CongressFebruary 25, 2025 | globenewswire.comDBV Technologies (NASDAQ:DBVT) Shares Cross Above Fifty Day Moving Average - Time to Sell?DBV Technologies (NASDAQ:DBVT) Share Price Passes Above 50 Day Moving Average - Here's WhyFebruary 18, 2025 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Now Covered by StockNews.comStockNews.com began coverage on DBV Technologies in a research note on Tuesday. They issued a "hold" rating on the stock.February 18, 2025 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Stock Passes Above 50 Day Moving Average - Here's What HappenedDBV Technologies (NASDAQ:DBVT) Share Price Passes Above 50-Day Moving Average - Time to Sell?January 25, 2025 | marketbeat.comStockNews.com Begins Coverage on DBV Technologies (NASDAQ:DBVT)StockNews.com initiated coverage on DBV Technologies in a research report on Saturday. They set a "hold" rating on the stock.January 25, 2025 | marketbeat.comHalf-Year Report on the DBV Technologies Liquidity Contract with ODDO BHFJanuary 13, 2025 | globenewswire.comDBV Technologies' (DBVT) "Market Outperform" Rating Reaffirmed at JMP SecuritiesJMP Securities reissued a "market outperform" rating and set a $10.00 price target on shares of DBV Technologies in a report on Friday.January 10, 2025 | marketbeat.comPositive Outlook on Viaskin Peanut Treatment Drives Buy Rating for DBV TechnologiesJanuary 10, 2025 | markets.businessinsider.comStockNews.com Initiates Coverage on DBV Technologies (NASDAQ:DBVT)StockNews.com initiated coverage on DBV Technologies in a research note on Thursday. They set a "hold" rating on the stock.January 9, 2025 | marketbeat.comDBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension StudyJanuary 8, 2025 | markets.businessinsider.comDBV Technologies (NASDAQ:DBVT) Shares Pass Below Fifty Day Moving Average - Should You Sell?DBV Technologies (NASDAQ:DBVT) Stock Price Crosses Below Fifty Day Moving Average - Time to Sell?January 1, 2025 | marketbeat.comDBV Technologies Amends Executive Severance AgreementsDecember 20, 2024 | markets.businessinsider.comDBV Technologies Aligns with FDA for Viaskin Peanut ApprovalDecember 13, 2024 | markets.businessinsider.comDBV jumps 52% to $4.99 after aligning with FDA on approval pathwayDecember 12, 2024 | markets.businessinsider.comDBV Technologies announces FDA alignment on Viaskin Peanut patch program pathwayDecember 12, 2024 | markets.businessinsider.comStocks to Watch: Adobe, Champions Oncology, DBV TechnologiesDecember 11, 2024 | marketwatch.comDBV Shares Rise 31%, Confirms Alignment With FDA on Accelerated Approval for Peanut PatchDecember 11, 2024 | marketwatch.comDBV stock rallies post-market on FDA Viaskin updateDecember 11, 2024 | seekingalpha.comDBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-OldDecember 11, 2024 | globenewswire.comDBV Technologies price target raised to $10 from $5 at JMP SecuritiesDecember 6, 2024 | markets.businessinsider.comDBV Technologies S.A. (NASDAQ:DBVT) Short Interest Down 5.3% in NovemberDBV Technologies S.A. (NASDAQ:DBVT - Get Free Report) was the recipient of a large decline in short interest in the month of November. As of November 15th, there was short interest totalling 1,260,000 shares, a decline of 5.3% from the October 31st total of 1,330,000 shares. Based on an average trading volume of 671,600 shares, the short-interest ratio is currently 1.9 days. Approximately 1.3% of the shares of the company are sold short.December 3, 2024 | marketbeat.comEleven option delistings on November 18thNovember 18, 2024 | markets.businessinsider.comDBV Technologies announces ADS ratio changeNovember 13, 2024 | markets.businessinsider.comDBV Technologies Stock to Reverse Split on Friday, November 29th (NASDAQ:DBVT)DBV Technologies S.A. (NASDAQ:DBVT - Free Report)'s stock is set to reverse split on the morning of Friday, November 29th. The 1-5 reverse split was announced on Monday, November 11th. The number of shares owned by shareholders will be adjusted after the market closes on Thursday, November 28th.November 13, 2024 | marketbeat.comDBV Technologies Announces Plan to Implement ADS Ratio ChangeNovember 11, 2024 | globenewswire.comDBV Technologies Reports Third Quarter 2024 Financial ResultsNovember 6, 2024 | globenewswire.comDBV Technologies (NASDAQ:DBVT) Stock Passes Above Fifty Day Moving Average - Here's WhyDBV Technologies (NASDAQ:DBVT) Stock Price Passes Above Fifty Day Moving Average - Here's WhyNovember 6, 2024 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Research Coverage Started at StockNews.comStockNews.com began coverage on shares of DBV Technologies in a report on Tuesday. They set a "hold" rating for the company.October 29, 2024 | marketbeat.comDBV Technologies rating suspended at Goldman SachsOctober 25, 2024 | markets.businessinsider.comHC Wainwright Has Positive Estimate for DBVT FY2024 EarningsDBV Technologies S.A. (NASDAQ:DBVT - Free Report) - Research analysts at HC Wainwright increased their FY2024 earnings per share estimates for DBV Technologies in a report issued on Wednesday, October 23rd. HC Wainwright analyst A. Fein now anticipates that the company will post earnings per sharOctober 25, 2024 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Price Target Increased to $7.00 by Analysts at HC WainwrightHC Wainwright increased their price objective on DBV Technologies from $5.00 to $7.00 and gave the company a "buy" rating in a research report on Thursday.October 24, 2024 | marketbeat.comFrench Biotech Stock Soars On Regulatory UpdatesOctober 24, 2024 | msn.comDBV Technologies price target raised to $7 from $5 at H.C. WainwrightOctober 24, 2024 | markets.businessinsider.comDBV Tech spikes after regulatory update on lead assetOctober 24, 2024 | seekingalpha.com Remove Ads Get DBV Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for DBVT and its competitors with MarketBeat's FREE daily newsletter. Email Address DBVT Media Mentions By Week DBVT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DBVT News Sentiment▼-0.060.80▲Average Medical News Sentiment DBVT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DBVT Articles This Week▼71▲DBVT Articles Average Week Remove Ads Get DBV Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for DBVT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ChromaDex News Nuvation Bio News AbCellera Biologics News CureVac News Xencor News Prothena News Replimune Group News Arbutus Biopharma News KalVista Pharmaceuticals News ArriVent BioPharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DBVT) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DBV Technologies S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share DBV Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
